Description
NM5A
NAD+100mg + MOTS-c 10mg + 5 Amino – 1mq 10mg
NAD+, MOTS-c, and 5-Amino-1MQ is a research combination of a dinucleotide coenzyme, a mitochondrial-encoded peptide, and a small-molecule NNMT inhibitor. It is supplied as a high-purity lyophilized blend for laboratory use only.
The blend typically contains NAD+ (100 mg), MOTS-c (10 mg), and 5-Amino-1MQ. NAD+ is nicotinamide adenine dinucleotide, a redox coenzyme. MOTS-c is a 16-amino-acid mitochondrial peptide typically described by the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg. 5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic quinolinium compound investigated as an NNMT inhibitor. Together they are used in controlled laboratory studies of compound identity, stability, and related biochemical pathways. Each component is typically verified by appropriate analytical methods such as HPLC and, where applicable, mass spectrometry.
In laboratory and preclinical research, this combination has been investigated in models of NAD+ metabolism, mitochondrial peptide signaling, cellular energy pathways, and NNMT-related methylation activity. These findings are limited to research settings and do not establish approved medical use.
This material is not approved for human or veterinary use and is not intended for consumption.
Reviews
There are no reviews yet.